February 18, 2013

@ldtimmerman: "immunotherapy could someday become a standard approach"

Third Rock’s Latest, Jounce, Grabs $47M For Cancer Immunotherapy by Xconomy's Luke Timmerman.

I found the following two quotes interesting.

The key to PV-10 is to properly understand the relationship between chemoablation and immune-mediated signaling. It is what Craig means when he says the immune system responds in direct proportion to the degree of insult. PV-10 chemoablation is the proxy for the degree of insult, which is rapid, complete and durable in the case of PV-10.

No comments:

Post a Comment